Our Pricing

Buy Mounjaro Online in Northern Ireland - UK Delivery

Published on: June 03, 2026

If you're looking to buy Mounjaro online in Northern Ireland, Cured Pharmacy offers a fully regulated service with UK-registered prescribers, transparent pricing from £124.99 and discreet delivery across all NI postcodes. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription to ensure you receive genuine, MHRA-licensed tirzepatide with the clinical support you deserve.

How Mounjaro Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, which work together to reduce appetite, slow gastric emptying, and improve insulin sensitivity.

In the SURMOUNT-1 clinical trial, participants receiving the 15 mg maintenance dose of tirzepatide achieved an average body weight reduction of 22.5% over 72 weeks, compared to 2.4% with placebo [1]. This dual-action mechanism has consistently demonstrated superior weight loss outcomes compared to GLP-1-only therapies in head-to-head studies [2].

Patients across Northern Ireland can access Mounjaro through our online consultation service, which connects you with UK-registered prescribers who assess your medical history, current medications, and weight management goals before issuing a prescription.

Mounjaro Dosing and Treatment Timeline

Each Mounjaro KwikPen contains four weekly doses, delivered via a pre-filled, single-use injector pen that requires no separate needles or preparation. You'll inject subcutaneously into your abdomen, thigh, or upper arm on the same day each week, at any time of day, with or without food.

Clinical data from the SURMOUNT trials showed that weight loss continues progressively throughout the first 72 weeks of treatment, with the most significant reductions occurring between weeks 20 and 60 [1]. Your UK prescriber will monitor your progress through follow-up consultations to determine the optimal duration of therapy for your individual circumstances.

Starting Your Mounjaro Journey

Mounjaro treatment follows a structured dose-escalation schedule designed to minimise gastrointestinal side effects whilst optimising weight loss results [3]. You'll begin with a 2.5 mg once-weekly injection for the first four weeks, which serves as an initial tolerability dose rather than a therapeutic dose.

Your prescriber will then increase your dose to 5 mg weekly, with further increases to 7.5 mg, 10 mg, 12.5 mg, or 15 mg at four-week intervals, depending on your response and tolerability. Most patients reach their maintenance dose within 20 to 24 weeks of starting treatment [3].

Mounjaro vs Wegovy: Comparing Weight Loss Injections

Wegovy remains an effective option for many patients and may be preferred if you've previously responded well to liraglutide (Saxenda) or if cost is a primary consideration, as Wegovy starts from £135.00 compared to Mounjaro's starting price of £124.99. However, when comparing clinical efficacy, tirzepatide consistently achieves higher average percentage body weight reductions in published trials.

Your UK prescriber will consider your medical history, previous weight loss attempts, concurrent medications, and personal preferences when recommending between Mounjaro and Wegovy. Both medications require the same commitment to dietary modification and increased physical activity for optimal results, and both carry similar gastrointestinal side effect profiles during the initial titration phase.

Key Differences Between Tirzepatide and Semaglutide

Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are once-weekly injectable medications licensed by the MHRA for chronic weight management, but they differ in their mechanisms and clinical outcomes [1][2]. Wegovy activates only GLP-1 receptors, whilst Mounjaro activates both GIP and GLP-1 receptors, producing a dual hormonal effect.

In the SURPASS-2 trial, which directly compared tirzepatide to semaglutide 1 mg in patients with type 2 diabetes, tirzepatide demonstrated superior weight loss across all dose levels [4]. The highest tirzepatide dose (15 mg) produced 5.5 kg greater weight reduction than semaglutide over 40 weeks. Similar patterns emerged in weight-management-focused trials comparing the two medications [1][2].

Ordering Mounjaro Online in Northern Ireland

Cured Pharmacy operates as a fully registered UK online pharmacy (GPhC registration 9012511), serving patients across Northern Ireland with the same clinical standards and regulatory oversight as traditional high-street pharmacies. Our online consultation process takes under three minutes and connects you directly with UK-registered prescribers who can assess your suitability for Mounjaro.

After completing your medical questionnaire, a UK prescriber reviews your information within 24 hours. If Mounjaro is clinically appropriate and you meet the NICE eligibility criteria for weight management therapy, they'll issue an electronic prescription which our pharmacy team dispenses and ships in discreet, unbranded packaging to your Northern Ireland address.

We guarantee transparent upfront pricing with no hidden consultation fees or subscription charges. The price you see before starting your assessment is the final price you'll pay, which includes the medication, prescriber review, and UK-wide delivery. Our customer service team is available on (+44) 116 4646009 if you have questions about your order or treatment.

Common Side Effects and Safety Considerations

Mounjaro is contraindicated if you have a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, as tirzepatide caused thyroid C-cell tumours in rodent studies [3]. Your prescriber will screen for these conditions during your consultation and review your full medical history to identify any contraindications.

You should not use Mounjaro if you're pregnant, planning pregnancy, or breastfeeding, as GLP-1 receptor agonists can cause foetal harm. Women of childbearing potential should use effective contraception during treatment and discontinue Mounjaro at least two months before a planned pregnancy [3]. Always inform your prescriber of all medications you're taking, as Mounjaro can delay gastric emptying and potentially affect the absorption of oral medications.

Managing Gastrointestinal Symptoms

The most frequently reported side effects of Mounjaro are gastrointestinal in nature, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort [3]. These symptoms typically occur during the initial dose-escalation phase and tend to decrease in intensity as your body adapts to the medication over several weeks.

In the SURMOUNT-1 trial, nausea was reported by 31% of participants on the 15 mg dose, compared to 8% in the placebo group, but most cases were mild to moderate in severity and resolved without discontinuing treatment [1]. Eating smaller, more frequent meals and avoiding high-fat foods can help minimise these effects during the first few months of therapy.

Maximising Your Results with Mounjaro

Whilst Mounjaro produces significant weight loss through its appetite-suppressing and metabolic effects, clinical trials demonstrate that the best outcomes occur when medication is combined with behavioural modifications [1]. NICE guidelines for weight management recommend that all pharmacological treatments should be prescribed alongside a reduced-calorie diet and increased physical activity programme.

Patients who engage with structured lifestyle interventions whilst taking tirzepatide achieve greater weight loss and are more likely to maintain their results after treatment ends. This includes working with a dietitian or nutritionist to develop sustainable eating patterns, gradually increasing physical activity to at least 150 minutes of moderate-intensity exercise per week, and addressing psychological factors that contribute to weight gain.

Your UK prescriber may recommend regular follow-up consultations to monitor your progress, adjust your dose if needed, and provide ongoing support throughout your treatment journey. Cured Pharmacy offers continued prescription services for patients who respond well to Mounjaro, ensuring you maintain access to your medication without interruption as long as it remains clinically appropriate.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen – Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14298 [accessed 13 August 2026]
4. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.